Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
First Affiliated Hospital of Zhejiang University
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
Allogene Therapeutics
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
City of Hope Medical Center
Loyola University